Edition:
United Kingdom

Mitsubishi Tanabe Pharma Corp (4508.T)

4508.T on Tokyo Stock Exchange

1,168JPY
23 Aug 2019
Change (% chg)

¥6 (+0.52%)
Prev Close
¥1,162
Open
¥1,170
Day's High
¥1,173
Day's Low
¥1,162
Volume
780,900
Avg. Vol
1,147,864
52-wk High
¥1,951
52-wk Low
¥1,128

Latest Key Developments (Source: Significant Developments)

Mitsubishi Tanabe Pharma Corp - To Transfer Shares In Unit Tanabe Seiyaku Yoshiki Factory To Nipro Pharma
Monday, 4 Feb 2019 

Mitsubishi Tanabe Pharma Corp <4508.T>::MITSUBISHI TANABE PHARMA CORP - TO TRANSFER SHARES IN UNIT TANABE SEIYAKU YOSHIKI FACTORY TO NIPRO PHARMA.  Full Article

Mitsubishi Tanabe Pharma updates license agreement with Kolon Life Secience on Invossa
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Mitsubishi Tanabe Pharma Corp <4508.T>:Says it notified Kolon Life Secience, Inc. (KLS) that the co seeks to cancel the license agreement between the co and KLS for Invossa, a cell therapy product for improvement of knee osteoarthritis symptoms .Says it has started negotiation with KLS regarding the cancellation of the License Agreement .  Full Article

Kaken Pharmaceutical signs exclusive distribution agreement for Clenafin/Jublia in Taiwan
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Kaken Pharmaceutical Co Ltd <4521.T>:Says co signed an exclusive distribution agreement with Tai Tien Pharmaceuticals Co Ltd (Tai Tien), which is a subsidiary of Mitsubishi Tanabe Pharma Corporation <<<4508.T>>>, for the topical formulation for Onychomycosis "Clenafin/Jublia" (product) in Taiwan.According to the agreement, co grants to Tai Tien the exclusive right for sales of the product in Taiwan and Tai Tien expects to launch the product in 2018.  Full Article

Mitsubishi Tanabe Pharma completes purchase of NeuroDerm
Wednesday, 18 Oct 2017 

Oct 18(Reuters) - Mitsubishi Tanabe Pharma Corp <4508.T>:Says it completed purchase of NeuroDerm Ltd <<>>.Purchase plan was announced on July 24.  Full Article

Mitsubishi Tanabe Pharma sells drug sales unit
Monday, 2 Oct 2017 

Oct 2(Reuters) - Mitsubishi Tanabe Pharma Corp <4508.T>:Says it sold 100 percent stake in a drug sales unit to Nipro, on Oct. 1.Previous plan was announced on March 28.  Full Article

‍Mitsubishi Tanabe Pharma America says signs agreement with Option Care for national home infusion services​
Wednesday, 6 Sep 2017 

Sept 6 (Reuters) - Mitsubishi Tanabe Pharma Corp <4508.T>:‍Mitsubishi Tanabe Pharma America says signs agreement with Option Care for national home infusion services​.‍Mitsubishi Tanabe Pharma America says agreement with Option Care Enterprises to become a national provider of home infusion services for Radicava​.  Full Article